Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Junji Furuse et al.|The Lancet|2023Cited by 1k
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of YapYoungmin A. Lee, Scott L. Friedman, Luke A. Noon et al.|Nature Communications|2018Cited by 162